Current and historical daily PE Ratio for GNIIF (
GNI Group Ltd
) from 2013 to Jun 13 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. GNI Group stock (GNIIF) PE ratio as of Jun 13 2024 is 11.6.
More Details
GNI Group Ltd (GNIIF) PE Ratio (TTM) Chart
GNI Group Ltd (GNIIF) PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Total 1247
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| GNI Group PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-13 | 9.7 | 2024-04-10 | 9.7 |
| 2024-06-12 | 9.7 | 2024-04-09 | 9.7 |
| 2024-06-11 | 9.7 | 2024-04-08 | 9.7 |
| 2024-06-10 | 9.7 | 2024-04-05 | 9.7 |
| 2024-06-07 | 9.7 | 2024-04-04 | 9.7 |
| 2024-06-06 | 9.7 | 2024-04-03 | 9.7 |
| 2024-06-05 | 9.7 | 2024-04-02 | 9.7 |
| 2024-06-04 | 9.7 | 2024-04-01 | 9.7 |
| 2024-06-03 | 9.7 | 2024-03-28 | 9.7 |
| 2024-05-31 | 9.7 | 2024-03-27 | 11.2 |
| 2024-05-30 | 9.7 | 2024-03-26 | 11.2 |
| 2024-05-29 | 9.7 | 2024-03-25 | 11.2 |
| 2024-05-28 | 9.7 | 2024-03-22 | 11.2 |
| 2024-05-24 | 9.7 | 2024-03-21 | 11.2 |
| 2024-05-23 | 9.7 | 2024-03-20 | 11.2 |
| 2024-05-22 | 9.7 | 2024-03-19 | 11.2 |
| 2024-05-21 | 9.7 | 2024-03-18 | 11.2 |
| 2024-05-20 | 9.7 | 2024-03-15 | 11.2 |
| 2024-05-17 | 9.7 | 2024-03-14 | 11.2 |
| 2024-05-16 | 9.7 | 2024-03-13 | 11.2 |
| 2024-05-15 | 9.7 | 2024-03-12 | 11.2 |
| 2024-05-14 | 9.7 | 2024-03-11 | 11.2 |
| 2024-05-13 | 9.7 | 2024-03-08 | 11.2 |
| 2024-05-10 | 9.7 | 2024-03-07 | 11.2 |
| 2024-05-09 | 9.7 | 2024-03-06 | 11.2 |
| 2024-05-08 | 9.7 | 2024-03-05 | 11.2 |
| 2024-05-07 | 9.7 | 2024-03-04 | 11.2 |
| 2024-05-06 | 9.7 | 2024-03-01 | 11.2 |
| 2024-05-03 | 9.7 | 2024-02-29 | 11.2 |
| 2024-05-02 | 9.7 | 2024-02-28 | 11.2 |
| 2024-05-01 | 9.7 | 2024-02-27 | 11.2 |
| 2024-04-30 | 9.7 | 2024-02-26 | 11.2 |
| 2024-04-29 | 9.7 | 2024-02-23 | 11.2 |
| 2024-04-26 | 9.7 | 2024-02-22 | 11.2 |
| 2024-04-25 | 9.7 | 2024-02-21 | 11.2 |
| 2024-04-24 | 9.7 | 2024-02-20 | 11.2 |
| 2024-04-23 | 9.7 | 2024-02-16 | 11.2 |
| 2024-04-22 | 9.7 | 2024-02-15 | 11.2 |
| 2024-04-19 | 9.7 | 2024-02-14 | 11.2 |
| 2024-04-18 | 9.7 | 2024-02-13 | 11.2 |
| 2024-04-17 | 9.7 | 2024-02-12 | 11.2 |
| 2024-04-16 | 9.7 | 2024-02-09 | 11.2 |
| 2024-04-15 | 9.7 | 2024-02-08 | 11.2 |
| 2024-04-12 | 9.7 | 2024-02-07 | 11.2 |
| 2024-04-11 | 9.7 | 2024-02-06 | 11.2 |
GNI Group Ltd (GNIIF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
GNI Group Ltd
ISIN : JP3386370005
Compare
Compare
Traded in other countries / regions
2160.Japan3G6.GermanyGNIIF.USA IPO Date
2013-06-17Description
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers